A 56-year-old man presented with mild anemia, a slight increase in platelets (leukocyte count, 4920/µL; hemoglobin, 11.5 g/dL; platelet count, 375 × 103/μL), and mild splenomegaly. A postmediastinal mass was noted on computed tomography (arrow; panel A). The resected mass was ∼2.5 cm in diameter (panel B). Histologically, the lesion was trilineage hematopoietic tissue and diagnosed as extramedullary hematopoiesis (EMH) with erythroid predominance (panels C and E; hematoxylin and eosin stain [C], CD71 [E]; original magnification ×200). Hypolobular granulocytes and megaloblastic change in erythroid cells were found on touch specimen (panel D; May-Giemsa stain, original magnification ×600). Dysplastic megakaryocytes (panel F; CD61, original magnification ×400), aggregation of fetal hemoglobin–positive cells (panel G, arrows; original magnification ×200), and a few scattered p53+ cells were also observed. CD34+ blasts did not increase. Because peripheral blood abnormalities remained, bone marrow aspiration was performed. Histologically, the findings were similar to those of EMH; however, Berlin blue staining revealed many sideroblasts in the clot, which were confirmed to be ring sideroblasts on the smear specimen (58% of erythroid series, panels H and I, arrows; May-Giemsa stain [H], Berlin blue stain [I]; original magnification, ×1000). Berlin blue staining for EMH tissue was performed afterward, and many sideroblasts were detected. (panel J, original magnification, ×1000). BCR-ABL, JAK2, MPL, and CALR mutation and del(5q) tests were negative genetically (SF3B1 mutation testing not performed).
The final diagnosis was myelodysplastic syndrome with ring sideroblasts.